Wolfe Repass plans sale of FLD common shares
Wolfe Repass submitted a notice related to potential sales of common stock of FLD.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Wolfe Repass submitted a notice related to potential sales of common stock of FLD. The filing lists a proposed transaction involving 1,180 common shares, connected with restricted stock vesting dated July 31, 2026, and a proposed sale date of August 3, 2026 on NASDAQ. It also details several prior sales of common stock by Wolfe Repass over the preceding three months, including multiple transactions in May, June, and July 2026 with specified share amounts and total consideration.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for FLD indicate?
What prior FLD stock sales by Wolfe Repass are disclosed in this Form 144?
What total consideration amounts are shown for recent Wolfe Repass FLD sales?
How is restricted stock vesting connected to the FLD Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.